DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sodelglitazar
Sodelglitazar
Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach
Us 2018 / 0296525 A1
The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
Research Article to Probe Full and Partial Activation
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Exploration and Development of PPAR Modulators in Health and Disease: an Update of Clinical Evidence
WO 2016/066666 Al 6 May 2016 (06.05.2016) P O P C T
WO 2016/066668 Al 6 May 2016 (06.05.2016) P O P C T
To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated
) (51) International Patent Classification: TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, I
Pharmaabkommen A1 E
Synthetic and Natural Peroxisome Proliferator‑Activated Receptor (PPAR) Agonists As Candidates for the Therapy of the Metabolic Syndrome
Exploration and Development of PPAR Modulators in Health and Disease : an Update of Clinical Evidence
25 Amino Acids 26 Chemicals 27 – 35 Nutritionals 36 – 52
Eight. E. N. Spung Sapplication Is for Complete Arch R"
Pharmaceutical Products and Chemical Intermediates, Fourth Review: Advice Concerning the Addition of Certain Products to the Pharmaceutical Appendix to the HTS
Prevention and Therapy of Type 2 Diabetes by Selective Modulation of the Human Peroxisome Proliferator-Activated Receptor Gamma (Pparγ)
Aminotetrahydropyrans As Dipeptidyl
Top View
Supplementary Materials: Building and Testing Pparγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Kernel Methods for Virtual Screening
WO 2014/022528 Al 6 February 2014 (06.02.2014) P O P C T
Peroxisome Proliferator-Activated Receptors: Features, Functions, and Future
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Synthesis and Biological Evaluation of Regulators of Peroxisome Proliferator-Activated Receptors
WO 2017/095725 Al 8 June 2017 (08.06.2017) W P O P C T
Prevention and Therapy of Type 2 Diabetes by Selective Modulation of the Human Peroxisome Proliferator-Activated Receptor Gamma (Pparγ)
9. Introduction.Pdf
To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations
Evaluation of the Anti-Diabetic Activity of Some Common Herbs and Spices: Providing New Insights with Inverse Virtual Screening
A Pharmacovigilance Approach for Assessing Cardiovascular